Parenteral Perspectives
Exploring innovations, challenges, and future horizons in parenteral drug delivery.
This author has not written his bio yet.
But we are proud to say that Laura Harris contributed 16 entries already.
Exploring innovations, challenges, and future horizons in parenteral drug delivery.
For this roundtable, Contract Pharma called upon thought leaders across the pharmaceutical services sector to address “3 Key Trends” impacting the CDMO industry in 2025 and beyond.
Bringing a sterile injectable product from development to commercialization requires a seamless scale-up process—one that minimizes risk, optimizes efficiency, and ensures regulatory success. In this exclusive webinar, experts from August Bioservices will discuss the critical factors that make or break a successful scale-up, sharing insights from a CDMO’s unique perspective.
CDMO leaders talk about navigating a dynamic landscape of innovation and demand.
Jenn Adams recognized in The Healthcare Technology Report, ” The Top 50 Women Leaders in Healthcare Technology of 2024″. In a rapidly changing and evolving industry, these executives are helping chart a course for an industry that is projected to hit $1 trillion within the next 10 years.
August Bioservices’ VP of Operations offers his thought leadership.
Will be used to add an additional sterile injectable filling suite to support high-speed liquid vial filling.
August Bioservices’ Chief Commercial Officer offers his thought leadership.
Contract Pharma called upon thought leaders across the pharmaceutical services sector to offer insight on key trends influencing the market.
Exploring innovations, challenges, and future horizons in parenteral drug delivery.$23.6 million investment from Polaris Partners will expand manufacturing capacity and capabilities to support production of sterile injectables.